MDR1 Inhibition Reverses Doxorubicin-Resistance in Six Doxorubicin-Resistant Canine Prostate and Bladder Cancer Cell Lines

Acquired chemoresistance during chemotherapy, often accompanied by cross- and multi-resistance, limits therapeutic outcomes and leads to recurrence. In order to create in vitro model systems to understand acquired doxorubicin-resistance, we generated doxorubicin-resistant sublines of canine prostate...

Descripción completa

Detalles Bibliográficos
Autores principales: Packeiser, Eva-Maria, Engels, Leoni, Nolte, Ingo, Goericke-Pesch, Sandra, Murua Escobar, Hugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179448/
https://www.ncbi.nlm.nih.gov/pubmed/37175843
http://dx.doi.org/10.3390/ijms24098136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179448/
https://www.ncbi.nlm.nih.gov/pubmed/37175843
http://dx.doi.org/10.3390/ijms24098136

Ejemplares similares